Calamos Advisors’s Twist Bioscience TWST Stock Holding History

Calamos Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,694	Closed	-$281K	–	997
2024 Q2	$281K	Buy	+5,694	New	+$232K	﹤0.01%	753

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Calamos Advisors's TWST Position: Q3 2024 in Review

Calamos Advisors sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 5,694 shares — an estimated $281K sold.

Calamos Advisors first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $281K in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

Calamos Advisors reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
Calamos Advisors sold 5,694 Twist Bioscience shares in Q3 2024, an estimated $281K.
Calamos Advisors first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
Calamos Advisors's Twist Bioscience position peaked at $281K in Q2 2024.
245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Calamos Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.